Literature DB >> 27443376

Hypertensive disorders of pregnancy.

Ana Sjaus1, Dolores M McKeen2, Ronald B George1.   

Abstract

PURPOSE: In this continuing professional development module, we review recent Society of Obstetricians and Gynaecologists of Canada (SOGC) guidelines for the classification and diagnosis of hypertensive disorders of pregnancy (HDP) as well as review the clinical features, laboratory investigations, and outcomes of HDP. We explore the evidence for anesthetic management and prevention of end-organ damage in women with HDP and describe the role and contribution of anesthesiologists as part of a multidisciplinary care team. PRINCIPAL
FINDINGS: Hypertensive disorders of pregnancy can have variable presentations with clinical signs and symptoms that often do not correlate with the underlying severity and progression of the disease. Failure of timely diagnosis and treatment contributes significantly to adverse maternal (neurologic complications, pulmonary edema, and postpartum hemorrhage) and neonatal (respiratory and neurologic complications and stillbirth) outcomes. In the Canadian context, improvements in medical care have led to better maternal and neonatal outcomes. Timing of delivery is crucial in balancing maternal risks and fetal benefits of ongoing pregnancy. Evidence-based SOGC guidelines regarding diagnosis and management of HDP address many aspects of clinical care relevant to anesthesiologists, who have an important role in the multidisciplinary care team.
CONCLUSIONS: Hypertensive disorders of pregnancy are on the rise worldwide, and this trend is expected to continue. The major contributors to maternal mortality are failure to recognize HDP promptly or to treat the condition adequately. It is essential that anesthesiologists understand the disease process and acquire knowledge of the guidelines governing current obstetrical care in order to provide evidence-based multidisciplinary quality care to these patients. Anesthetic management helps prevent potentially deleterious maternal and fetal outcomes.

Entities:  

Mesh:

Year:  2016        PMID: 27443376     DOI: 10.1007/s12630-016-0689-8

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  9 in total

1.  A Case of Preeclampsia with Uterine Necrosis after Uterine Artery Embolization for Postpartum Hemorrhage.

Authors:  Midori Yoshikawa; Takahiro Seyama; Takayuki Iriyama; Seisuke Sayama; Tatsuya Fujii; Masatake Toshimitsu; Moto Nakaya; Ryo Kurokawa; Eisuke Shibata; Takeyuki Watadani; Keiichi Kumasawa; Takeshi Nagamatsu; Kaori Koga; Yutaka Osuga
Journal:  Case Rep Obstet Gynecol       Date:  2022-05-17

2.  Risk factors for eclampsia in pregnant women with preeclampsia and positive neurosensory signs.

Authors:  Houssam Rebahi; Megan Elizabeth Still; Yassine Faouzi; Ahmed Rhassane El Adib
Journal:  Turk J Obstet Gynecol       Date:  2019-01-09

Review 3.  Riding the Rhythm of Melatonin Through Pregnancy to Deliver on Time.

Authors:  Ronald McCarthy; Emily S Jungheim; Justin C Fay; Keenan Bates; Erik D Herzog; Sarah K England
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-13       Impact factor: 5.555

4.  Association between ambient temperature and hypertensive disorders in pregnancy in China.

Authors:  Juan Liang; Dezhi Mu; Tao Xiong; Peiran Chen; Yi Mu; Xiaohong Li; Baofeng Di; Jierui Li; Yi Qu; Jun Tang
Journal:  Nat Commun       Date:  2020-06-10       Impact factor: 14.919

5.  Second trimester maternal serum D-dimer combined with alpha-fetoprotein and free β-subunit of human chorionic gonadotropin predict hypertensive disorders of pregnancy: a systematic review and retrospective case-control study.

Authors:  Yiming Chen; Yijie Chen; Xue Wang; Xuelian Chu; Wenwen Ning; Linyuan Gu; Liyao Li; Zhen Xie; Caihe Wen
Journal:  J Transl Med       Date:  2021-03-02       Impact factor: 5.531

Review 6.  COVID-19, Pre-Eclampsia, and Complement System.

Authors:  Chiara Agostinis; Alessandro Mangogna; Andrea Balduit; Azin Aghamajidi; Giuseppe Ricci; Uday Kishore; Roberta Bulla
Journal:  Front Immunol       Date:  2021-11-17       Impact factor: 7.561

7.  Hypertensive disorders in pregnancy and stillbirth rates: a facility-based study in China.

Authors:  Tao Xiong; Yi Mu; Juan Liang; Jun Zhu; Xiaohong Li; Jinke Li; Zheng Liu; Yi Qu; Yanping Wang; Dezhi Mu
Journal:  Bull World Health Organ       Date:  2018-06-12       Impact factor: 9.408

Review 8.  Acute Kidney Injury in Pregnancy: The Need for Higher Awareness. A Pragmatic Review Focused on What Could Be Improved in the Prevention and Care of Pregnancy-Related AKI, in the Year Dedicated to Women and Kidney Diseases.

Authors:  Giorgina Barbara Piccoli; Elena Zakharova; Rossella Attini; Margarita Ibarra Hernandez; Bianca Covella; Mona Alrukhaimi; Zhi-Hong Liu; Gloria Ashuntantang; Alejandra Orozco Guillen; Gianfranca Cabiddu; Philip Kam Tao Li; Gulliermo Garcia-Garcia; Adeera Levin
Journal:  J Clin Med       Date:  2018-10-01       Impact factor: 4.241

9.  Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany.

Authors:  Dietmar Schlembach; Martin Hund; Annabel Schroer; Cyrill Wolf
Journal:  BMC Health Serv Res       Date:  2018-08-06       Impact factor: 2.655

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.